4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-21-024888
EVP, General Counsel sold 50,455 shares at an average $82.46 ($4,160,559)
- EVP, General Counsel acquired 97,001 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Rivera Jose E · EVP, General Counsel
Table I: Non-derivative
25 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-01 | Exercise or conversion : show line 1 in the form | +33,000 | $13.88 | $458,040 | 148,842 | D |
| 2021-04-01 | Sale : show line 2 in the form | −2,010 | $80.79 | $162,388 | 146,832 | D |
| 2021-04-01 | Sale : show line 3 in the form | −8,266 | $81.89 | $676,903 | 138,566 | D |
| 2021-04-01 | Sale : show line 4 in the form | −3,233 | $82.76 | $267,563 | 135,333 | D |
| 2021-04-01 | Sale : show line 5 in the form | −3,234 | $83.91 | $271,365 | 132,099 | D |
| 2021-04-01 | Sale : show line 6 in the form | −1,067 | $84.94 | $90,631 | 131,032 | D |
| 2021-04-01 | Exercise or conversion : show line 7 in the form | +21,000 | $18.30 | $384,300 | 152,032 | D |
| 2021-04-01 | Sale : show line 8 in the form | −1,256 | $80.82 | $101,510 | 150,776 | D |
| Open-market sales · 50,455 sh · avg $82.46 · $4,160,559 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-01 | Exercise or conversion : show line 26 in the form Stock Option (right to buy) | −33,000 | 39,000 | D |
| 2021-04-01 | Exercise or conversion : show line 27 in the form Stock Option (right to buy) | −21,000 | 29,090 | D |
| 2021-04-01 | Exercise or conversion : show line 28 in the form Stock Option (right to buy) | −10,000 | 51,000 | D |
| 2021-04-01 | Exercise or conversion : show line 29 in the form Stock Option (right to buy) | −33,001 | 6,116 | D |
Loading xslF345X03/doc4.xml…